Open Citations
Comparative Study of Additive IOP Lowering Effects and Safety Profile of Ripasudil 0.4% Combined with Timolol 0.5% and Ripasudil 0.4% Combined with Bimatoprost 0.03% In Primary Open Angle Glaucoma in Indian Eyes
0
Open Citations
Last updated: 2026-10-03 22:30:02
Citing Works
No open citing works have been identified for this article yet.